Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.

In Colombia, bariatric surgery is on the rise—more than 20,000 procedures are performed each year, making the country one of Latin America’s top destinations for this type of weight-loss ...

Preoperative GLP-1RA use was not significantly associated with an increased risk for postoperative aspiration pneumonia or acute respiratory failure.

A new guideline for treating obesity in children and adolescents says medication can be helpful, but that health providers ...

Glucagon-like peptide 1 receptor agonist therapy over a 12-month period is safe and effective in treating weight regain ...

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in ...

Canada's new obesity guidelines signal a shift in food consumption, with GLP-1 drugs impacting how and what Canadians—especially youth—eat.

I’m Kelly Grant, a health reporter with The Globe and Mail. Yesterday, the Canadian Medical Association Journal published the first new guideline on the treatment of childhood obesity in nearly 20 ...

It's not clear which children would benefit, when to start the drugs and, once started, whether children would have to stay ...

In addition to emphasizing traditional strategies such as healthy eating, physical activity, and behavioural support, the new ...

GLP-1s like Ozempic, as well as weight-loss surgery, are among the recommendations to treat childhood obesity in the first guideline update in Canada in almost 20 years.

New guidelines for treating children with obesity in Canada says doctors may need to consider weight loss drugs and bariatric surgery for teenagers. Nivrita Ganguly has the details and more in Health ...